Which has the lower trailing P/E, NBIX or SOLV?

SOLV has the lower trailing P/E: NBIX trades at 21.34 and SOLV at 10.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, NBIX or SOLV?

Over the past five years, NBIX grew revenue faster — NBIX at a 26.74% CAGR versus SOLV at 2.72%.

Is NBIX or SOLV more profitable?

NBIX runs the higher net margin — NBIX at 20.91% versus SOLV at 17.26%.

Neurocrine Biosciences, Inc. (NBIX) vs Solventum Corporation (SOLV)

A side-by-side comparison of Neurocrine Biosciences, Inc. and Solventum Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NBIX

Neurocrine Biosciences, Inc.

$14.63B

$145.51HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SOLV

Solventum Corporation

$15.07B

$87.04HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NBIX vs SOLV

growth of $100 · dividends reinvested · last 3y

NBIX +2.2% (+0.7%/yr)SOLV +10.0% (+3.2%/yr)SOLV compounded faster over this window

NBIX SOLV

NBIX vs SOLV: by the numbers

•SOLV is the larger company ($15.07B vs $14.63B market cap).
•SOLV trades at the lower trailing earnings multiple (10.63 vs 21.34 P/E), one valuation lens rather than an overall verdict.
•NBIX converts more revenue to profit (20.91% vs 17.26% net margin).
•NBIX grew revenue faster over the past five years (26.74% vs 2.72% CAGR).

Metrics side by side

Valuation

Metric	NBIX	SOLV
P/E ratio	21.34	10.63
Forward P/E	20.60	12.15
PEG ratio	9.12	1.74
P/S ratio	4.34	1.81
P/B ratio	3.96	3.14
EV / EBITDA	17.58	7.01
FCF yield	5.92%	N/A

Profitability

Metric	NBIX	SOLV
Gross margin	97.97%	54.69%
Operating margin	23.38%	24.99%
Net margin	20.91%	17.26%
ROE	19.10%	29.88%
ROIC	13.20%	15.85%

Growth (annualized)

Metric	NBIX	SOLV
Revenue CAGR (5Y)	26.74%	2.72%
EPS CAGR (5Y)	1.94%	6.26%
FCF CAGR (5Y)	28.69%	N/A
Total return CAGR (5Y)	7.56%	N/A

Frequently asked

Which has the lower trailing P/E, NBIX or SOLV?: SOLV has the lower trailing P/E: NBIX trades at 21.34 and SOLV at 10.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, NBIX or SOLV?: Over the past five years, NBIX grew revenue faster — NBIX at a 26.74% CAGR versus SOLV at 2.72%.
Is NBIX or SOLV more profitable?: NBIX runs the higher net margin — NBIX at 20.91% versus SOLV at 17.26%.

Go deeper

Full NBIX analysis Full SOLV analysis Interactive comparison tool

Dig into the metrics

Neurocrine Biosciences P/E ratio Solventum P/E ratio Neurocrine Biosciences ROE Solventum ROE Neurocrine Biosciences operating margin Solventum operating margin Neurocrine Biosciences revenue growth Solventum revenue growth Neurocrine Biosciences free cash flow Solventum free cash flow

Neurocrine Biosciences & Solventum appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.